Free drug monitoring

Clinics in Laboratory Medicine

Volumn 7, Issue 2, 1987, Pages 279-287

  Chan, S ^a   Gerson, B ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL;

EID: 0023267352     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30744-3     Document Type: Review

References (24)

1. Anavekar S.N. Wardell W.M. Shoulson I. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations Clin Pharm Ther 24 1978 629
2. Bickel MH: Pharmacological Consequences of Plasma Protein and Tissue Binding of Drugs, Transport by Proteins. In Blauer G (ed): New York, de Gruyter, 1978, pp. 325-329
3. Borga A. Piafsky K.M. Nielson O.G. Plasma protein binding of basic drugs. I. Selective displacement from alpha-1-acid glycoprotein by Tris-(2-bytoxyethyl) phosphate Clin Pharmacol Ther 22 1977 539
4. Cramer J.A. Bennet D.B. Mattson R.H. Free and bound valproic acid separated by two methods of ultrafiltration Clin Chem 29 1983 1441
5. Cronin M.K. Application of an innovative ultrafiltration system for free drug determinations Clin Pharmacol Ther 29 1981 238
6. Evans G.H. Nies A.S. Shand D.G. The disposition of propranolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog, and rat J Pharmacol Exp Ther 186 1973 114
7. Gerson B. Essentials of Therapeutic Drug Monitoring 1983 Igaku-Shoin New York 1 54
8. Gerson B. Monitoring Free Drug Levels Special Topics. Check Sample 22 (No. 84-6) 1984 ASCP Chicago
9. Jusko W.J. Gretch M. Plasma and tissue protein binding of drugs in pharmacokinetics Drug Metab Rev 5 1976 43
10. Kurz H. Trunk H. Weitz B. Evaluation of methods of determining protein binding of drugs Arzenim Forsch 27 1977 1373
11. Maas J.W. Lipton M.A. Clinical Implications of Pharmacological Differences Among Antidepressants. Psychopharmacology: A Generation of Progress 1978 Raven Press New York 955 960
12. McElnay J.C. D’Arey P.F. Protein binding displacement interactions and their clinical significance Drugs 25 1983 495
13. Mucklow J.C. The use of saliva in therapeutic drug monitoring Ther Drug Monit 4 1982 229
14. Orsulak P.S. Sink M. Weed J. Blood collection tubes for tricyclic antidepressant drugs: A reevaluation Ther Drug Monit 6 1984 444
15. Piafsky K.M. Disease-induced changes in the plasma binding of basic drugs Clin Pharmacokinet 5 1980 246
16. Pila E. The relative importance of albumin, lipoproteins, and orosomucoid for drug serum binding Clin Pharmacol 9 Suppl 1 1984 84
17. Reidenberg M.M. Drayer D.E. Alteration of drug-protein binding in renal diseases Clin Pharmacokinet 9 Suppl 1 1984 18
18. Ruprak M. Perucca E. Richens A. Spuriously high values of unbound drug fraction in serum as determined by the new ultrafree anticonvulsant drug filters Br J Clin Pharmacol 12 1981 753
19. Schildkraut J.J. Lipton M.A. Clinical Implications of Pharmacological Dif ferences Among Antidepressants. Psychopharmacology: A Generation of Progress 1978 Raven Press New York 955 960
20. Shang-Quiang J. Evenson M.A. Effect of contaminants in blood-collection devices on measurement of therapeutic drugs Clin Chem 29 1983 456
21. Shaw LM: Free drug measurement. AACC, May 1983
22. Svensson C.K. Woodruff M.N. Baxter J.G. Laika D. Free drug concentration monitoring in clinical practice Clin Pharmacokinet 11 1986 450 469
23. Whitby L.G. Percy-Robb I.W. Smith A.F. Lecture Notes on Clinical Chemistry 1975 Blackwell Scientific Publications Oxford, England 9 10
24. Whitlan J.B. Brown K.F. Ultrafiltration in serum protein binding determinations J Pharm Sci 70 1981 146